Towards precision radiation oncology: endocrine therapy response as a biomarker for personalization of breast radiotherapy

S. M.Nashir Udden; Guem Hee Baek; Kamal Pandey; Chantal Vidal; Yulun Liu; Asal S. Rahimi; D. Nathan Kim; Chika Nwachukwu; Ram S. Mani; Prasanna G. Alluri

doi:10.1038/s41698-023-00348-1

Towards precision radiation oncology: endocrine therapy response as a biomarker for personalization of breast radiotherapy

S. M.Nashir Udden, Guem Hee Baek, Kamal Pandey, Chantal Vidal, Yulun Liu, Asal S. Rahimi, D. Nathan Kim, Chika Nwachukwu, Ram S. Mani, Prasanna G. Alluri

Research output: Contribution to journal › Article › peer-review

Abstract

Targeted therapies, such as endocrine therapies (ET), can exert selective pressure on cancer cells and promote adaptations that confer treatment resistance. In this study, we show that ET resistance in breast cancer drives radiation resistance through reprogramming of DNA repair pathways. We also show that pharmacological bromodomain and extraterminal domain inhibition reverses pathological DNA repair reprogramming in ET-resistant breast tumors and overcomes resistance to radiation therapy.

Original language	English (US)
Article number	11
Journal	npj Precision Oncology
Volume	7
Issue number	1
DOIs	https://doi.org/10.1038/s41698-023-00348-1
State	Published - Dec 2023

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1038/s41698-023-00348-1

Cite this

@article{2ea2e67e27074ffeb75bf79af8110b97,

title = "Towards precision radiation oncology: endocrine therapy response as a biomarker for personalization of breast radiotherapy",

abstract = "Targeted therapies, such as endocrine therapies (ET), can exert selective pressure on cancer cells and promote adaptations that confer treatment resistance. In this study, we show that ET resistance in breast cancer drives radiation resistance through reprogramming of DNA repair pathways. We also show that pharmacological bromodomain and extraterminal domain inhibition reverses pathological DNA repair reprogramming in ET-resistant breast tumors and overcomes resistance to radiation therapy.",

author = "Udden, {S. M.Nashir} and Baek, {Guem Hee} and Kamal Pandey and Chantal Vidal and Yulun Liu and Rahimi, {Asal S.} and Kim, {D. Nathan} and Chika Nwachukwu and Mani, {Ram S.} and Alluri, {Prasanna G.}",

note = "Publisher Copyright: {\textcopyright} 2023, The Author(s).",

year = "2023",

month = dec,

doi = "10.1038/s41698-023-00348-1",

language = "English (US)",

volume = "7",

journal = "npj Precision Oncology",

issn = "2397-768X",

publisher = "Springer Nature",

number = "1",

}

TY - JOUR

T1 - Towards precision radiation oncology

T2 - endocrine therapy response as a biomarker for personalization of breast radiotherapy

AU - Udden, S. M.Nashir

AU - Baek, Guem Hee

AU - Pandey, Kamal

AU - Vidal, Chantal

AU - Liu, Yulun

AU - Rahimi, Asal S.

AU - Kim, D. Nathan

AU - Nwachukwu, Chika

AU - Mani, Ram S.

AU - Alluri, Prasanna G.

PY - 2023/12

Y1 - 2023/12

N2 - Targeted therapies, such as endocrine therapies (ET), can exert selective pressure on cancer cells and promote adaptations that confer treatment resistance. In this study, we show that ET resistance in breast cancer drives radiation resistance through reprogramming of DNA repair pathways. We also show that pharmacological bromodomain and extraterminal domain inhibition reverses pathological DNA repair reprogramming in ET-resistant breast tumors and overcomes resistance to radiation therapy.

AB - Targeted therapies, such as endocrine therapies (ET), can exert selective pressure on cancer cells and promote adaptations that confer treatment resistance. In this study, we show that ET resistance in breast cancer drives radiation resistance through reprogramming of DNA repair pathways. We also show that pharmacological bromodomain and extraterminal domain inhibition reverses pathological DNA repair reprogramming in ET-resistant breast tumors and overcomes resistance to radiation therapy.

UR - http://www.scopus.com/inward/record.url?scp=85146813405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85146813405&partnerID=8YFLogxK

U2 - 10.1038/s41698-023-00348-1

DO - 10.1038/s41698-023-00348-1

M3 - Article

C2 - 36693944

AN - SCOPUS:85146813405

SN - 2397-768X

VL - 7

JO - npj Precision Oncology

JF - npj Precision Oncology

IS - 1

M1 - 11

ER -

Towards precision radiation oncology: endocrine therapy response as a biomarker for personalization of breast radiotherapy

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this